Shared mechanisms of alcohol and other drugs.

Identifying the changes that occur in the brain as a result of alcohol and other drug (AOD) use is important to understanding the development of AOD addiction. The nerve cell signaling chemical (i.e., neurotransmitter) γ-aminobutync acid (GABA) plays an important role in the brain chemistry of addiction. Most drugs interact with binding molecules (i.e., receptors) for specific neurotransmitters and either block or facilitate binding at these receptors. Thus, cannabis and opiates act via receptors intended for internally derived (i.e., endogenous) cannabinoid and opiate substances. In contrast, alcohol does not appear to activate specific receptors. However, alcohol influences the activity of many transmitter systems including GABA and endogenous opioids and cannabinoids.

A lcohol and other drug (AOD) use creates a huge health burden for the United States and epresents one of the most imposing medical and socioeconomic concerns for our society (Harwood et al. 2003;Kessler et al. 2005). Drug addiction comprises many complex behaviors in which an individual becomes increasingly preoccupied with obtaining drugs, leading to a loss of control over consumption and to the development of tolerance, dependence, and impaired social and occupational functioning (Hoffman and Tabakoff 1996;Koob et al. 1998). Current research aims to understand which specific nerve cells (i.e., neurons) and subcellular systems undergo molecular changes with drug exposure that lead to chronic drug abuse. This article will review our current understanding of how alcohol, opioids, and cannabinoids 1 interact with the key substances in the brain, such as γ−aminobutyric acid (GABA), and with each other.

Neuroadaptation
An important element in the development of drug addiction is the brain's attempt to chemically counteract the influences of the drug (i.e., neuroadap tation). Neurobiological research on addiction focuses on uncovering the neuroadaptative mechanisms within specific brain circuits that mediate the transition from occasional and controlled drug use to loss of control over drug-seeking and drug-taking behav iors that define chronic addiction. In the last two decades, animal models have provided much information on the molecular mechanisms involved in the positive reinforcing effects of drugs. For example, such research has provided evidence implicating the neurotransmitter 2 dopamine and the brain circuit through which it is transmitted (i.e., the mesocorticolimbic dopamine system) in the rewarding effects of AODs. More recently, specific components of the group of structures located near the bottom of the front of the brain (i.e., basal forebrain) have been implicated in the drug reward system and have been termed the "extended amygdala" 3 (Koob 2003). The extended amygdala is composed of a group of structures, including the nucleus accum bens 4 (NAcc), the central nucleus of the amygdala (CeA), and the bed nucleus of stria terminalis 5 (BNST). The extended amygdala now is considered to play an important role in both the acute reinforcing effects of drug use and the negative effects of compulsive drug use on reward function (Koob 2003).
In addition to these neural circuits, systems of neurotransmitters and neuromodulators 6 such as GABA, opioid peptides, and endogenously formed cannabinoids (i.e., endo cannabinoids [eCBs]) have been found to be involved in the acute reinforcing effects of drug use. Researchers recently have identified interactions between alcohol, eCBs, and opioids. Specifically, these interactions affect transmissions of GABA that depress the activity of the cell on which they act (i.e., inhibitory synaptic transmission). 7 Numerous sensory neurons, and most of the neurons that connect sensory neurons to each other (i.e., interneu rons), contain GABA and control local synaptic networks, suggesting that GABA is a critical regulator of the transmission of nerve signals. Because opioids, cannabinoids, and alcohol act on the same transmitter (GABA) in the same brain regions (the CeA), dissecting these drug interactions on a common cellular target could uncover a key neuroad aptative site and cellular mechanisms triggered by abused substances. This article reviews the actions and inter actions of alcohol and opioid and cannabinoid substances on the amyg dalar GABAergic system.
Fine-tuning the GABAergic inhibitory system in the CeA is a pre requisite for controlling the neurons that transmit to the nuclei down stream of the CeA. Most of the CeA neurons are GABAergic (Cassell et al. 1999;Sun and Cassell 1993) and are either inhibitory neurons with recur rent or feedforward connections 8 or inhibitory neurons that project to the brainstem or BNST targets. The CeA can be thought of as a "gate" that regulates the flow of information through the intra-amygdaloidal circuits, leading to changes in the inhibition of downstream regions. The following section will discuss how alcohol affects the GABAergic system and how these alterations may functionally influence the neuronal responsivity of the inhibitory CeA gating. In addition to the modulation of GABAergic transmission by alcohol, opioids, and cannabinoids, this article also will describe direct interactions that take place among these drugs. Research ultimately may be able to more directly address the cellular and synaptic neu roadaptations associated with the development of drug addiction. Understanding the cross-talk (i.e., nerve cell communication) between these systems may be critical for the development of new treatments for drug addiction and abuse and also may be helpful for combination therapy (Cichewicz 2004a).

Alcohol's Actions on GABA Transmission
The most consistent effect of alcohol on the brain is to reduce neuronal activity by a combination of effects that increases the inhibitory action of GABA and decreases the excitatory action of the neurotransmitter glutamate. GABAergic transmission is sensitive to alcohol in several brain regions and is involved in the acute actions of alcohol as well as long-term effects, such as the develop ment of tolerance and dependence (Criswell and Breese 2005;Siggins et al. 2005;Weiner and Valenzuela 2006). To better define the potential interac tions taking place on the amygdalar GABAergic system, it is important to know how alcohol alters GABA trans mission and, in turn, how GABAergic activity modulates AOD-seeking behaviors. Behavioral studies have implicated GABAergic transmission in regulating alcohol intake. The reinforc ing effect of alcohol is prevented by administering agents into the CeA that block receptors (i.e., receptor antago nists) for GABA A (a subtype of GABA receptor) and opioids (Heyser et al. 1999;Hyytia and Koob 1995). Other studies (Merlo Pich et al. 1995;Roberts et al. 1996) found that alcohol-dependent rats appeared to have enhanced sensi tivity to agents that mimic GABA A receptors (i.e., receptor agonists). Furthermore, activation of GABA A receptors in the CeA decreases alcohol self-administration only in alcoholdependent rats (Roberts et al. 1996), indicating increased GABAergic trans mission in alcohol reinforcement and dependence.
Research at the cellular level impli cates GABA in the intoxicating effects of alcohol (Martz et al. 1983). In studies of CeA samples from rats, Roberto and colleagues (2003) showed that the increase in GABAergic trans mission is related to the dose, or amount, of alcohol supplied (see fig  ure 1), which acts principally at a presynaptic site to augment GABA release. Furthermore, Roberto and colleagues (2004) confirmed the presynaptic effect of alcohol on GABA release in an in vivo microdialysis study that showed increased dialysate 9 GABA levels in the CeA 3 The amygdalae (singular amygdala) are almond-shaped groups of neurons located deep within the medial tempo ral lobes of the brain. They encompass several nuclei, or structures in the central nervous system, including the central, lateral, and basal nuclei. 4 The nucleus accumbens is a group of neurons located in the forebrain that is thought to play a role in reward, pleasure, addiction, and fear. 5 The bed nucleus of stria terminalis is an area of the hypothalamus. 6 Neuromodulators are similar to neurotransmitters and change the way neurons react to those neurotransmitters. 7 Communication among neurons typically occurs across microscopic gaps called synaptic clefts. A neuron sending a signal (i.e., a presynaptic neuron) releases a neurotrans mitter, which binds to a receptor on the surface of the receiving (i.e., postsynaptic) neuron. Excitatory neurotrans mitters activate the postsynaptic cell and inhibitory neuro transmitters depress the activity of the postsynaptic cell. 8 Feedforward connections maintain a condition in its cur rent state rather than allowing a change in the system. 9 Microdialysis is a technique used to analyze the chemical components of tissues. A solution (i.e., the dialysate) is pumped through a semipermeable membrane inserted into the tissue. Molecules in the tissue diffuse into the dialysate as it is pumped through the membrane and the dialysate is then collected and analyzed to determine the identities and concentrations of molecules that were in the tissue.
when alcohol was infused (Roberto et al. 2004). The investigators also assessed whether GABAergic synaptic changes occur with alcohol depen dence in rat CeA. In CeA neurons from dependent rats, basal GABAergic transmission (via increased tonic GABA release 10 ) was significantly higher than in non-alcohol-dependent rats. Moreover, acute alcohol still increased GABAergic transmission (see figure 1), suggesting a lack of tol erance to the acute effects of alcohol (Roberto et al. 2004). In addition, the in vivo data showed a four-fold increase of baseline dialysate GABA concentrations in the CeA of alcoholdependent rats compared with nondependent rats and confirmed the lack of tolerance to the acute local administration of alcohol by increased dialysate GABA levels in alcohol-dependent rats.
In summary, the findings of Roberto and colleagues (2004) point to a significant effect of alcohol on GABAergic transmission in the CeA that markedly adapts during the development of alcohol dependence. The mechanism of alcohol's effect remains to be fully elucidated but primarily is associated with an action upon GABA release. Most of the CeA neurons used in this research are 10 Tonic release means that GABA constantly is being released from the terminals, even without electrical stimu lation. In dependent animals, tonic release is "increased," meaning that the amount of GABA released is greater than in nondependent animals.

A B
Nondependent Rats Dependent Rats Figure 1 Alcohol enhances transmission of the neurotransmitter γ-aminobutyric acid (GABA) in the central nucleus of the amyg dala (CeA). A) Top: Representative recordings of GABA-mediated inhibitory postsynaptic currents (IPSCs) in a CeA slice from a non-alcohol-dependent rat recorded before, during, and after the slice was exposed to alcohol (i.e., superfused*). Bottom: Pooled data showing that superfusion of alcohol (44 mM) significantly increased the average IPSC amplitudes in CeA neurons from non-alcohol-dependent rats. B) Top: IPSC recordings in a CeA slice from an alcoholdependent rat. Bottom: Alcohol significantly increased the mean IPSC amplitudes in alcohol-dependent rats.
NOTES: The CeA is one of a group of brain structures that plays an important role in both the acute reinforcing effects of drug use and the negative effects of compulsive drug administration on the reward function part of the drug reward system. IPSCs reflect the transmission of chemical signals between neurons across microscopic gaps called synaptic clefts. A neuron sending a signal (i.e., a presynaptic neuron) releases a neurotransmitter, which binds to a receptor on the surface of the receiving (i.e., post synaptic) neuron. Inhibitory neurotransmitters, such as GABA, depress the activity of the postsynaptic cell. Error bars (on A and B, bottom) represent standard error. *Superfusion is to flush a fluid over the surface of a tissue. SOURCE: Roberto et al. 2003Roberto et al. , 2004 GABAergic inhibitory interneurons with inhibitory recurrent or feedforward connections as well as projections to downstream nuclei. Functionally, alcohol itself may influence the neu ronal responsivity of the inhibitory CeA gating that regulates information flow through the intra-amygdaloidal circuits (e.g., by disinhibition of CeA), altering the inhibition of the downstream regions (e.g., BNST) by altering GABA release there (see figure 2).

Presynaptic Terminal
GABAergic Interneuron Opioids eCBs Figure 2 Hypothetical action of alcohol on γ-aminobutyric acid (GABA)-releasing synapses in the central nucleus of the amygdala. Upper synapse: Alcohol enhances the release of GABA from the presynaptic terminals of the same or another GABAergic interneuron. Lower synapse: Activation of presynaptic opioid or cannabinoid receptors (e.g., CB1) may reduce GABA release onto this interneuron, leading to increased excitability.

Alcohol Research & Health 140
The Opioid System Opioids decrease both excitatory (glu tamatergic) and inhibitory (GABAergic) synaptic transmission (Siggins et al. 2003;Williams et al. 2001). The opi oid-induced decrease of GABAergic transmission can occur via inhibition of GABAergic interneurons and GABA release, resulting in the disinhibition of descending neurons 11 in a circuit. Via this disinhibition, opioids have excita tory actions in multiple regions of the nervous system in vivo, despite their inhibitory effects at the cellular level (Charles and Hales 2004). This mecha nism mediates the pain-relieving effects of opioids (Christie et al. 2000) as well as the effects involved in opioid depen dence (Williams et al. 2001;Xi and Stein 2002). In the brain region known as the ventral tegmental area (VTA), opioids bind to the receptor subtypes µand perhaps δ-receptors found on GABA interneurons or GABA projec tion neurons that interact with dopaminergic neurons, causing disinhi bition of dopaminergic cell firing (Wise 1998). Although all the major types of opioid receptors are present in the NAcc, opioid actions have not been well characterized and may even be independent of the dopamine system in this brain region. In the NAcc, opi oids inhibit the release of GABA at synapses between medium spiny neu rons 12 and interneurons, causing decreased inhibitory responses (Chieng and Williams 1998).
The CeA has one of the highest immunoreactive densities of enkephalins 13 in the brain. Enkephalin is localized in the cell bodies of GABAergic neu rons, the most abundant type of neu ron in the CeA (Veinante et al. 1997). Moderate levels of µ-receptors (i.e., a subtype of opioid receptors) are found in the CeA (Chieng et al. 2006), where their activation decreas es excitatory and inhibitory transmis sion via a presynaptic action (Finnegan et al. 2005).
In addition, activation of opioid receptors in the CeA reportedly opens ion channels (see sidebar) to inhibit CeA neurons (Chieng et al. 2006). Zhu and Lovinger (2005) suggested that the µ-receptors are the only functional opioid receptors localized on the glutamatergic projections to the CeA, and their activation leads to an inhibition of glutamatergic trans mission. Another study (Finnegan et al. 2005) found that presynaptic µ receptors localized on the neurons carrying impulses to the CeA and projecting to a midbrain structure called the periaqueductal gray area decreased GABAergic but not gluta matergic transmission. Together, these findings indicate that µ-receptors can modulate release of both GABA and glutamate.
Preliminary data by the authors of this article indicate that µ-receptordependent modulation of neuronal properties, as well as GABA and glu tamate transmission in the CeA, are complex and involve pre-and postsy naptic mechanisms. The mechanisms and the effects appear to be neuronal type-and circuitry-specific. Results 11 Descending neurons are neurons that carry information from the brain to the chest or abdominal region. 12 Medium spiny neurons are inhibitory and play a key role in initiating controlling movements of the body, limbs, and eyes. 13 Enkaphalins are endogenous compounds that bind to opioid receptors and are involved in regulating pain.
also are now available from neurons in CeA slices taken from morphinetreated rats. These results show no significant changes in either the intrinsic neuronal properties or synap tic properties in morphine-treated animals compared with naïve animals. However, exposure to a µ-receptor antagonist via superfusion 14 signifi cantly increased the amplitude of GABAergic transmission in the CeAs of both chronic morphine-treated and naïve animals, suggesting tonic (i.e., constant) activation of µ-receptors in both conditions.

The Endogenous Cannabinoid System
Cannabinoids act via a specific receptor (i.e., CB1) to alter central physiological processes such as cognition, locomo tion, appetite, and pain (Iversen 2003). CB1s are among the most abundantly expressed neuronal receptors and are found throughout the brain, including the amygdala (Freund et al. 2003). The discovery of specific cannabinoid receptors led to the isolation of endoge nously formed binding molecules (i.e., ligands), the eCBs. The principal eCBs, arachidonylethanolamide (anan damide) and 2-arachidonoylglycerol, are derived from fat molecules (i.e., lipids). These compounds are synthe sized and degraded by neurons (Piomelli 2003). CB1 agonists affect both inhibitory and excitatory synaptic transmission. The synthetic cannabi noid agonist WIN55212-2 (WIN) diminishes GABAergic and glutamater gic synaptic transmission in the NAcc and a region of the amygdala known as the basolateral amygdala (BLA) (Azad et al. 2003;Freund et al. 2003;Piomelli 2003). CB1 activation leads to presy naptic inhibition of GABAergic trans mission in globus pallidus 15 neurons and in the VTA. In the latter case, depression of the GABAergic inhibitory input of dopaminergic neurons likely increases their firing rate in vivo and consequently also increases dopamine release in the projection region of VTA neurons (e.g., NAcc).
In the BLA, eCB signaling has been implicated in the extinction of aversive memories (Marsicano et al. 2002). Zhu and Lovinger (2005) used freshly isolated BLA neurons to provide solid evidence of a retrograde eCB signaling 16 in the BLA. Little information is available on the expres sion and function of CB1 in the CeA. Katona and colleagues (2001) report ed that CB1 is expressed at high levels in certain amygdala nuclei, especially the lateral and basal nuclei, but are absent in the CeA. However, the authors recently conducted electro physiological experiments in CeA slices to investigate the cellular inter actions of the CB1 system and alco hol on GABAergic transmission (see below). These studies (Roberto et al., preliminary data) showed that superfu sion of the CB1 agonist WIN onto CeA neurons markedly reduced GABA transmission (see figure 3).
Cannabinoids also affect neuronal excitability at the postsynaptic level. In the hippocampus, CB1 ligands close a family of potassium channels (i.e., M-channels) also affected by alcohol (Moore et al. 1990;Schweitzer 2000), and the concurrent modula tion of M-channels by alcohol and cannabinoids could greatly affect neu ronal excitability. Cannabinoids also open potassium channels of the G protein-regulated inwardly rectifying K + channel (i.e., GIRK) type in trans fected cells 17 and have been linked to GIRK channels in the cerebellum. Interestingly, cannabinoid effects on synaptic transmission in the amyg dala also appear to implicate GIRK channels (Azad et al. 2003), and GIRK conductances have been impli cated in alcohol's effects (Lewohl et al. 1999). Thus, M-channels and GIRK channels are potential sites of interac tion between cannabinoids and alco hol at the postsynaptic level, and amygdala neurons display both M and GIRK currents (Meis and Pape 1998;Womble and Moises 1992).
Together, these results point to how the cannabinoid signaling system could be involved in some of the pharmaco logical effects of alcohol and a possible function for CB1 in alcohol tolerance and dependence, as discussed below. The eCB system may constitute part of a common brain pathway, mediating reinforcement of alcohol consumption and uncovering how the cannabinoid signaling system may provide a target for the treatment of alcoholism.

Interaction of Alcohol and the Opioid System
Alcohol and opioid drugs have numer ous behavioral effects in common, including sedation, motor depression, and rewarding experiences. Evidence exists to suggest that alcohol adminis tration alters the release of endogenous opioid peptides (Gianoulakis 2004;Oswald and Wand 2004). Additional evidence indicates that an alcoholinduced increase of opioid peptide release affects alcohol consumption, and nonselective opioid antagonists that block all opioid receptors, such as nalox one and naltrexone, reliably decrease alcohol intake (Gianoulakis 2004;Oswald and Wand 2004).

µ-Opioid Receptor
Pharmacological studies (Gianoulakis 2004;Oswald and Wand 2004) using subtype-specific antagonists show that the key element in opioid peptide sys tems involved in the positive reinforc ing effects of alcohol is the µ-opioid receptor. Accordingly, µ-receptor antag onists dose-dependently reduce alcohol intake, and animals bred to have no µ-receptors have greatly diminished alcohol consumption and anxiety-like behaviors (Filliol et al. 2000;Roberts et al. 2000), suggesting an interaction between anxiety-like behavior and alcohol use.
14 Superfusion is to flush a fluid over the surface of a tissue. 15 The globus pallidus is a structure in the brain involved in the regulation of voluntary movements at a subconscious level 16 Retrograde signaling is a phenomenon in which a signal travels from a postsynaptic neuron to a presynaptic one. 17 Transfected cells are cells into which foreign DNA has been inserted. In this case, the cells were manipulated to express GIRK channels.

δ-Opioid Receptor
In contrast, mice lacking the δ-opioid receptor drink significantly more than controls (Roberts et al. 2001), possibly because of an increased level of anxiety in these animals. However, it also has been proposed that δ-receptors may be involved in the aversive properties of alcohol consumption, and thus it is possible that the increased alcohol intake in δ-receptor-deficient mice is produced by a diminution of the aver sive effects of alcohol consumption. However, inconsistencies are found in the literature investigating the involve ment of δ-receptors in alcohol prefer ence and reward. For example, δ-recep tor antagonists decrease alcohol con sumption, and an inhibitor of the enzyme that breaks down enkephalins (i.e., enkephalinase) increases alcohol intake (Gianoulakis 2004;Oswald and Wand 2004), suggesting that δ-recep tors exert a facilitatory influence on alcohol consumption.

κ-Receptor
Considerably less information is avail able regarding the effect of κ-receptor ligands on alcohol self-administration. There is evidence that agonists for κ-receptors increase alcohol intake in Lewis rats (Lindholm et al. 2001), that alcohol-preferring rats have increased levels of the opioid prodynorphin in the thalamus and decreased κ-receptor densities in the hypothalamus com pared with alcohol-avoiding rats (Marinelli et al. 1998), and that there are significantly higher levels of dynor phin peptides (κ-receptors agonists) in the NAcc of alcohol-avoiding animals compared with alcohol-preferring ani mals (Terenius 1994). Although incon sistencies exist in the literature, the cumulative evidence presently available suggests that alcohol consumption increases the release of endogenous opi oid peptides and that µ-and δ-recep tors facilitate the relationship between alcohol consumption and reward. Although relatively little information is available on the effect of κ-receptors in the regulation of alcohol consumption, it often is concluded that these recep tors exert an inhibitory influence (for further review see Gianoulakis 2004;Herz 1997).

Alcohol and Opioid Interactions in the CeA
In several brain regions, acute alcohol has been shown to release endogenous opioids, which, in turn, mediate alco hol effects, such as reinforcement and the reduction of anxiety (Oswald and Wand 2004). Consistently, acute alco hol administration increases expression of the gene c-fos (indicative of increased neuronal activity), specifically in the enkephalin-containing GABAergic neurons in the CeA (Morales et al. 1998). In addition, injection of opioid recep tor antagonists into the CeA blocked the reinforcing effects of alcohol (Foster et al. 2004;Heyser et al. 1999).
Recent studies conducted in CeA slices showed that the alcohol-induced increase of GABAergic transmission was larger in mice without a func tional δ-receptor gene (i.e., δ-receptor knockout mice). In addition, a δ receptor inverse agonist, which binds to the same binding site as an agonist but exerts the opposite effect, augmented alcohol actions on GABAergic response in control mice to a level comparable with alcohol effects seen in δ-receptor knockout mice (Kang-Park et al. 2007). These findings suggest that endogenous opioids may reduce alcohol's actions on GABA transmis sion in CeA neurons through selec tive δ-receptor-mediated inhibition of GABA release and that the increased alcohol effect on GABA responses in the CeA of δ-receptor knockout mice could, at least in part, be attributed to the absence of selective δ-recep tor-mediated inhibition of GABA release. This result supports the hypothesis that endogenous opioid peptides modulate the alcoholinduced augmentation of GABA A receptor-dependent circuitry in the CeA . Ongoing studies suggest that baseline GABAergic transmission in the CeA is signifi cantly greater in µ-receptor knockout mice compared with control mice. However, alcohol increased the GABAergic transmission to a similar extent in both µ-receptor knockout and control mice. It is possible that greater baseline activity of GABAergic transmission underlies the decreased anxiety-like behaviors and decreased voluntary alcohol consumption in µ-receptor knockout mice. This result is consistent with the suggestion that activation of GABA receptors in the CeA, possibly leading to stress reduc tion, is involved in mediating alco hol-seeking and drinking behavior.

Interaction of Alcohol and the CB1 System
Chronic alcohol administration results in neurobiological alterations similar to those observed after chronic cannabi noid exposure (Mechoulam and Parker 2003). Recent behavioral and neuro chemical evidence suggests that CeA eCBs are involved in alcohol depen dence and the authors' recent work points to interactions between alcohol and eCBs on synaptic transmission in the CeA. The neuroadaptation to chronic alcohol exposure has been shown to involve changes in the CB1 system, including alterations in the synthesis of eCBs and their precursors, as well as a decrease in the number of CB1 receptors (Basavarajappa and Hungund 2002; Gonzalez et al. 2004). It is important to explore the components of the eCB system in different brain areas to fur ther understand how it may affect the development of alcohol dependence.
The eCBs acting at CB1 modulate alcohol consumption in rats, perhaps by affecting the activity of brain reward systems. The administration of a CB1 antagonist together with chronic alcohol treatment increases the preference for alcohol. In contrast, administration of a CB1 antagonist after chronic alcohol or at the time of withdrawal drastically diminishes alcohol preference and selectively reduces alcohol intake in alcoholpreferring rats (Serra et al. 2002). Similarly, acute administration of a CB1 antagonist suppresses only alco hol self-administration in alcoholdependent animals, whereas operant responses 18 for food are not affected. Further, chronic alcohol administration downregulates CB1 and increases the levels of the endogenous cannabinoid anandamide and the endogenous CB1 agonist 2-arachidonoylglycerol (Basavarajappa and Hungund 2002). These data suggest involvement of CB1 in alcohol reinforcement and a possible synergistic effect of eCBs in alcohol preference.
Cannabinoid ligands decrease GABA ergic transmission, and research by the authors has shown that alcohol augments GABAergic transmission in the CeA, thus acting in a direction opposite of cannabinoids. A reciprocal influence to modulate synaptic trans mission may therefore take place at inhibitory synapses. These results suggest that CB1 helps to regulate alcohol's effects in CeA neurons. Superfusion of the CB1 agonist WIN inhibited evoked GABA transmission (i.e., GABA transmission that was evoked by stimulation of neurons) and completely blocked alcoholinduced effects (see figure 3), and the WIN effect was prevented by a selective CB1 antagonist (not shown). Thus, the selective activation of CB1 interferes with alcohol's effects. Cannabinoids, by acti vating CB1 to decrease GABA trans mission in CeA neurons, will diminish alcohol's effects on the GABA system.
In summary, several lines of evidence designate the eCB system as a key player in the central effects of alcohol.
(1) Blockade of CB1 drastically dimin ishes alcohol preference, suggesting that endogenous CB1 ligands reinforce the preference for alcohol; (2) chronic alcohol exposure increases the levels of eCBs; (3) CB1 may play a critical role in stress-stimulated alcohol use; (4) CB1 antagonists suppress alcohol selfadministration but only in alcoholdependent animals; and (5) chronic alcohol downregulates CB1 and increases eCB levels.

A A A B
Time (min)

Interaction of the Opioid and Cannabinoid Systems
Interactions between the opioid and cannabinoid systems influence specific and, very often, reciprocal cross-talks regulating many aspects of drug addic tion (e.g. reward, dependence, toler ance, sensitization, and relapse) (Fattore et al. 2005(Fattore et al. , 2007. Behavioral evidence supporting interactions of opioid and cannabinoid systems in drug addiction includes (1) the block ade of some effects of the psychoactive compound Δ-9-tetrahydrocannabinol (THC) by opioid antagonists, (2) sup pression of opioid withdrawal signs by cannabinoids and induction of withdrawal symptoms in morphinedependent rats by CB1 antagonists, (3) precipitation of abstinence symptoms in THC-tolerant animals by naloxone, and (4) involvement of the cannabi noid and opioid systems in mecha nisms underlying relapse (Cichewicz 2004b;Fattore et al. 2004Fattore et al. , 2005Fattore et al. , 2007. At the molecular level, studies (Caille et al. 2007;Vigano et al. 2005) have shown (1) co-localization of CB1 and opioid receptors in various brain regions, (2) alterations of the endoge nous opioid system by exposure to cannabinoids and reciprocal alteration of the endogenous cannabinoid system by exposure to opioids, and (3) inhibi tion of cannabinoid stimulation of dopamine release in the NAcc by opioid antagonists. The mechanisms implicated in the interactions between opioids and cannabinoids involve several components of these systems, including alteration of the levels of endogenous ligands as well as their respective receptors. In addition, inter actions between cannabinoids and opioids can trigger the modulation of other transmitter systems, such as GABA, glutamate, dopamine, and cor ticotropin-releasing factor (CRF). The reciprocal alteration of endogenous levels of cannabinoids and opioids occurs in both acute and chronic states. Acute cannabinoid administration increases extracellular 18 A operant response is a behavior that is modifiable by its consequences. levels of endogenous dynorphin in the spinal cord (Houser et al. 2000;Mason et al. 1999;Pugh et al. 1997;Welch and Eads 1999) and enkephalin in the NAcc (Valverde et al. 2001). Similarly, chronic cannabinoid treat ment increases gene expression of prodynorphin (which is a precursor to dynorphin A and dynorphin B, both additional opioids) and the opioid proenkephalin in brain regions medi ating pain relief and drug dependence (Corchero et al. 1997a, b;Manzanares et al. 1998). Reciprocally, heroin selfadministration into the NAcc signifi cantly increases anandamide and decreases levels of the eCB 2-arachi donylglycerol in this brain region (Caille et al. 2007). In addition, acute morphine increases anandamide levels in the hippocampus, NAcc, and cau date putamen and decreases 2-arachi donylglycerol levels in the NAcc and hippocampus (Vigano et al. 2004), whereas chronic morphine markedly lowers 2-arachidonylglycerol content without changing anandamide levels Nerve Cell Communication electrical charges (i.e., impulses) thr N erve cells, or neurons, allow different parts of the body to communicate with each other by receiving, conducting, and transmitting oughout the ner vous system. Chemical messengers called neurotrans mitters carry information across small gaps or synapses that exist between neurons. A neuron sending a signal (i.e., a presynaptic neuron) releases a neurotransmitter, which binds to a receptor on the surface of the receiv ing (i.e., postsynaptic) neuron. Receptors are proteins with unique shapes that fit a specific neurotransmitter, much like a lock and key. For example, serotonin will only bind to serotonin receptors, not dopamine receptors.
The mechanism underlying neuronal signal trans mission is based on voltage differences (i.e., poten tials) that exist between the inside and the outside of the cell. This membrane potential is created by the uneven distribution of electrically charged particles, or ions, such as sodium (Na + ) and potassium (K + ). Ions enter and exit the cell through specific channels in the cell's membrane (i.e., ion channels). The channels "open" or "close" in response to neurotransmitters or to changes in the cell's membrane potential. Ligandgated ion channels regulate ion passage through interactions with neurotransmitters. Voltage-gated ion channels open and close in response to changes in membrane potential and are named for the ion (e.g., potassium) that passes through its pore. The resulting redistribution of electric charge may alter the voltage difference across the membrane. A decrease in the voltage difference is called depolariza tion. If depolarization exceeds a certain threshold, an impulse (i.e., action potential) will travel along the neuron. The generation of an action potential is sometimes referred to as "firing." Depolarization of a presynaptic neuron results in the release of neurotransmitters into the synapse. Glutamate is the predominant excitatory neurotrans mitter that promotes depolarization of a postsynaptic neuron, propagating an electrical signal. -Aminobutyric acid (GABA) is the major inhibitory neurotransmit ter that blocks depolarization of a postsynaptic neu ron. A neuron that makes a particular neurotransmit ter, and therefore has the potential to release it, is designated by the neurotransmitter name with the suffix -ergic (e.g., GABAergic). γ B A A) Neurons communicate by sending signals across microscopic gaps called synapses. These signals are conducted away from the neuron's cell body by long slender projections called axons. B) Signal transmission across a synapse. A neuron sending a signal releases a neurotransmitter (shown as triangles and circles), which binds to a receptor on the surface of the receiving neuron. Receptors are proteins with unique shapes that fit a specific neurotransmitter, much like a lock and key.
in these brain regions (Vigano et al. 2003(Vigano et al. , 2004. Interactions of the opioid and cannabinoid systems at the receptor level have been observed mainly after chronic morphine treatment. In various studies, chronic morphine produced divergent effects as well as brain region-dependent effects on CB1 binding and expression levels. These studies have shown no change Thorat and Bhargava 1994), decreased CB1 binding and expression in the cerebellum and hip pocampus (Vigano et al. 2003), and increased CB1 binding in the cau date-putamen and limbic structures (Gonzalez et al. 2002). Gonzalez and colleagues (2003) reported decreased CB1 binding in the midbrain and cerebral cortex of morphine-dependent rats. In cannabinoid-tolerant animals, studies show increased µ-opioid receptor density in several brain regions (Corchero et al. 2004). In the core of the NAcc, researchers have sug gested the allosteric (at a site other than the active site) binding of µ-opi oid receptor and CB1 (Schoffelmeer et al. 2006). This study also showed that activation of these receptors resulted either in an excitatory (i.e., glutamate release) or inhibitory (i.e., GABA release) effect.
In summary, acute administration of cannabinoids and opioids elicits cellular interactions, principally altering the levels of the respective endogenous ligands and subsequent activation or inhibition of the relevant receptors. However, prolonged exposure to opi oids and cannabinoids can trigger sus tained interactions between these systems that may lead to neuroadap tations taking place at all levels of these endogenous transmitter systems, including ligand concentration and receptor density. How neuronal activ ity actually is affected by these inter actions remains to be determined.

Conclusion
The combined evidence now available clearly establishes the vast progress recently made in our understanding of the brain synaptic circuitry implicated in the transition to drug dependence. In an attempt to uncover a common site of cellular action for abused sub stances, the authors focused on the GABAergic system, a critical modula tor of local synaptic activity in the CeA, a brain region considered to be a key element of the brain reward sys tem. This review focuses on alcohol, opioids, and cannabinoids because these drugs only recently have been shown to interact at GABAergic synapses in the CeA. In addition, the authors are familiar with these drugs and were able to report on data gener ated in their laboratories. Because there are no receptors or well-defined trans duction mechanisms for alcohol, the authors emphasize the cellular mecha nisms affected by alcohol. Other drugs of abuse such as psychostimulants (i.e., amphetamine, cocaine) and nicotine are not discussed here but are described in other recent reviews (DiFranza and Wellman 2007;Kalivas 2007;Rebec 2006).
Because the CeA is involved in alcohol reinforcement and depen dence, the authors envision that the influence of opioids and eCBs to block the facilitatory effects of alcohol on GABAergic transmission in the CeA is altered in dependent rats. Our hypothesis is that alcohol consump tion and dependence stimulates the release of endogenous cannabinoids and/or opioids, or stimulates these endogenous systems that function as "brakes" and limit the enhancement of GABAergic transmission by alco hol in the neural circuitry involved in reinforcement. Future studies assess ing the cellular actions of opioid and cannabinoid transmitters in the CeA and their modulation of alcohol's effects will likely lead to a better understanding of the cellular mecha nisms of drug addiction. The endoge nous opioid and cannabinoid transmit ter systems are emerging as promising targets for future medications to treat drug dependence. ■